SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The exhibit is a news release announcing the Board of Directors' declaration of third-quarter dividends payable on September 1, 2026, specifying per-share amounts for eight classes of preference shares and common shares. This is a routine but material dividend declaration, as dividend distributions are standard investor-relevant disclosures for a utility company with significant shareholder bases.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 filed under Item 2.02 (Results of Operations and Financial Condition). The press release discloses quarterly financial results including net sales of $158.1 million (19% increase YoY), diluted EPS of $0.43, and adjusted EPS of $0.52, along with comprehensive operational highlights and cash flow data. The filing explicitly states "On July 29, 2026, the Company issued a press release to stockholders and other interested parties regarding financial results for the second quarter ended June 27, 2026," with the press release furnished as Exhibit 99.1.
View raw filing on EDGAR →This exhibit is Fiverr's Q2 2026 earnings release, disclosing quarterly financial results including revenue of $97.8 million (down 10% YoY), net income of $4.5 million, and revised full-year 2026 guidance reflecting "AI-related demand and traffic headwinds." The document contains consolidated balance sheets, statements of operations and cash flows, and management commentary from the CEO and CFO. Material to investors as it reports significant revenue decline, reduced guidance, and strategic repositioning toward higher-value work in response to AI disruption.
View raw filing on EDGAR →This is a press release announcing Radware's second quarter 2026 financial results, dated July 29, 2026. The exhibit discloses record revenue of $82.3 million (11% YoY growth), Cloud ARR of $103 million (22% YoY growth), GAAP diluted EPS of $0.09, and non-GAAP diluted EPS of $0.30 from continuing operations, along with detailed consolidated financial statements (balance sheet, income statement, cash flow statement) and reconciliations. This is a classic earnings release event material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →This is an announcement of the timing and logistics for the release of Ceragon's second quarter 2026 financial results on August 11, 2026, with details on the investor conference call. While the actual earnings results have not yet been disclosed (they will be released on August 11), this exhibit is the advance notice of an earnings release event. The disclosure identifies the specific date, time, and format for earnings announcement and investor discussion, which is material to investors tracking the company's financial performance and guidance.
View raw filing on EDGAR →This is a press release explicitly labeled "EARNINGS RELEASE" disclosing Silicom's Q2 2026 financial results. The exhibit reports Q2 revenues of $23.8 million (59% YoY growth), net loss of $2.1 million GAAP (37% improvement YoY), and raises full-year revenue guidance to $93–$95 million (>50% YoY growth). The disclosure includes consolidated balance sheets, statements of operations, and non-GAAP reconciliations for both the three-month and six-month periods ended June 30, 2026, along with management commentary on strategic milestones including AI-Inference production orders and design wins. This is a material event affecting investor assessment of the registrant's financial performance and outlook.
View raw filing on EDGAR →The 6-K body discloses that Camtek Ltd. held an Annual General Meeting of Shareholders on July 29, 2026, and that "all of the proposals brought before the shareholders at the Meeting have been approved." This is a direct disclosure of shareholder vote results, matching the definition of Item 5.07 (shareholder_vote_results). The approval of all proposals at an annual meeting is material to investors' understanding of governance and shareholder support for management.
View raw filing on EDGAR →The disclosure announces the successful initiation of a Phase 2/3 clinical trial for SIL204 at Tel Aviv Sourasky Medical Center, marking a transition from regulatory preparation into active clinical execution. This is a material operational and clinical milestone for a clinical-stage biotechnology company, but does not fit the specific named event types (earnings, executive changes, M&A, impairment, etc.). The event is clearly operational/strategic in nature—a significant clinical development milestone—making operational_other the most appropriate classification.
View raw filing on EDGAR →This exhibit discloses preliminary select financial results for Q2 2026, including revenue ($447 million, +4% YoY), net loss ($53–65 million vs. $50 million in Q2 2025), and Adjusted EBITDA ($103 million, -2% YoY). Although labeled "preliminary" and subject to finalization before the August 13 earnings call, the document presents quarterly financial performance metrics in the format of a results announcement. The company explicitly states these are management estimates pending full financial reporting, but the disclosure of quarterly revenue, net loss, and adjusted EBITDA constitutes an earnings release under the 6-K framework.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 (quarter ended June 28, 2026). The Item 2.02 disclosure states that "Teradyne, Inc. issued a press release regarding its financial results for the second quarter ended June 28, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains detailed financial statements, revenue of $1,329 million (up 104% YoY), GAAP EPS of $2.38, and forward guidance for Q3 2026, all hallmarks of a quarterly earnings release.
View raw filing on EDGAR →SK hynix disclosed preliminary financial results for Q2 2026 (second quarter ending June 30, 2026), including revenue of 79.3 trillion Won, operating profit of 60.5 trillion Won, and net profit of 93.9 trillion Won. The filing explicitly states these are "Preliminary Results of Operations" prepared on a consolidated basis under K-IFRS, with a conference call scheduled for July 29, 2026. This is a quarterly earnings announcement material to investors assessing the company's financial performance.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 ended June 30, 2026. The press release discloses net income of $168.6 million, diluted EPS of $1.67, and detailed financial results including net interest margin, asset quality metrics, and balance sheet information. The filing explicitly states the press release was "publicly disseminated" on July 29, 2026, and is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases.
View raw filing on EDGAR →Parsons Corporation issued a press release on July 29, 2026, announcing financial results for the second quarter ended June 30, 2026, including revenue of $1.6 billion, net income of ($15 million), adjusted EBITDA of $42 million, and revised fiscal year 2026 guidance ranges. This is a standard quarterly earnings disclosure filed under Item 2.02 with the press release attached as Exhibit 99.1, meeting the definition of an earnings_release event.
View raw filing on EDGAR →Eagle Materials Inc. disclosed its quarterly financial results for the quarter ended June 30, 2026, via a press release furnished as Exhibit 99.1. The disclosure includes record revenue of $651.0 million, net earnings of $102.1 million, diluted EPS of $3.29, and detailed segment performance metrics. This is a standard quarterly earnings release filed under Item 2.02 (Results of Operations and Financial Condition), which is the primary vehicle for earnings disclosures in 8-K filings.
View raw filing on EDGAR →OneSpaWorld issued a press release on July 29, 2026 announcing second quarter fiscal 2026 financial results, including total revenues of $261.2 million, net income of $23.2 million, and adjusted EBITDA of $34.4 million. The filing explicitly states this is furnished pursuant to Item 2.02 of Form 8-K, "Results of Operations and Financial Condition," with the press release attached as Exhibit 99.1. This is a standard quarterly earnings release disclosing material financial performance metrics.
View raw filing on EDGAR →This is a clear earnings release disclosing Garmin's financial results for the fiscal second quarter ended June 27, 2026. The filing explicitly states "Garmin Ltd. ("the Company") issued a press release announcing its financial results for the fiscal second quarter ended June 27, 2026" and includes detailed financial statements showing record consolidated revenue of $2.02 billion (11% increase), record operating income of $616 million (30% increase), and raised full-year 2026 guidance. The press release is attached as Exhibit 99.1 and contains comprehensive quarterly and year-to-date financial data across all business segments.
View raw filing on EDGAR →Stepan Company issued a press release providing financial results for the second quarter ended June 30, 2026, reporting net income of $22.9 million (up 102% year-over-year) and adjusted net income of $27.1 million (up 126% year-over-year), with detailed segment performance data.
View raw filing on EDGAR →The Board approved a plan on July 28, 2026 to reduce the global salaried workforce by approximately 100 roles in Q3 2026 as part of Project Catalyst, with estimated charges of $4–6 million consisting primarily of severance and benefits.
View raw filing on EDGAR →Jan Stern Reed resigned from the Board effective July 27, 2026, and from all committees including her role as Chair of the Human Capital and Compensation Committee.
View raw filing on EDGAR →The Board declared a quarterly cash dividend on the Company's common stock of $0.395 per share, payable September 15, 2026.
View raw filing on EDGAR →This 8-K discloses supplemental amendments to a merger agreement between Axalta and AkzoNobel, including Amendment No. 2 dated July 23, 2026, and joinder agreements dated July 13, 2026, that modify governance arrangements and merger structure. The filing updates the definitive proxy statement in advance of the August 5, 2026 shareholder vote on the merger, which constitutes a material acquisition/change of control transaction requiring disclosure under Item 1.01 or 2.01.
View raw filing on EDGAR →Synlogic entered into a definitive Merger Agreement on July 28, 2026, to combine with Caldera Therapeutics through an all-stock transaction creating a new holding company (Sonic Holdco, Inc.), with the combined company operating as Caldera Therapeutics. Synlogic stockholders will own approximately 2.3% of the combined company post-closing, with the transaction expected to close by early 2027 subject to stockholder approval and customary closing conditions.
View raw filing on EDGAR →Watsco issued a press release on July 29, 2026 reporting financial results for the quarter and six months ended June 30, 2026, disclosing revenues of $2.1 billion for Q2, gross profit, operating income, and diluted earnings per share of $4.00 for Q2, along with segment performance and operational trends.
View raw filing on EDGAR →This is a clear earnings release for Monro, Inc.'s first quarter ended June 27, 2026. The Item 2.02 disclosure explicitly states that "Monro, Inc. (the 'Company') issued a press release announcing its financial results for the first quarter ended June 27, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains detailed quarterly financial results including sales ($287.1M, down 4.6%), operating income, net loss, and diluted EPS ($.08 loss per share), along with comparable store sales analysis and management commentary from the CEO.
View raw filing on EDGAR →This is a press release announcing New Oriental's unaudited financial results for the fourth fiscal quarter and full fiscal year ended May 31, 2026. The exhibit discloses comprehensive financial metrics including net revenues (US$1,529.5M for Q4, US$5,661.3M for FY2026), operating income, net income, and earnings per ADS, along with management commentary and forward guidance for FY2027. This is a classic earnings release event material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →This is a press release announcing Nomura Holdings' consolidated financial results for the first quarter of fiscal year 2026/27, filed on July 29, 2026. The document discloses net revenue of ¥686.7 billion (up 19% QoQ, 31% YoY), pretax income of ¥211.5 billion (up 96% QoQ, 32% YoY), and net income of ¥145.6 billion (up 97% QoQ, 39% YoY), along with divisional performance metrics and strategic highlights. This is a discrete earnings announcement, not a periodic financial report, and the results are material to investors assessing the registrant's financial performance and progress toward its 2030 targets.
View raw filing on EDGAR →LB Pharmaceuticals entered into a Securities Purchase Agreement on July 28, 2026, to issue 3,577,560 shares of common stock and pre-funded warrants to purchase 715,513 additional shares in a private placement for approximately $150 million in gross proceeds at $34.94 per share to institutional investors under Section 4(a)(2) exemption without registration.
View raw filing on EDGAR →CBIZ entered into a definitive Agreement and Plan of Merger with Grant Thornton Advisors (via Viking ParentCo and Viking MergerCo) on July 28, 2026, whereby CBIZ shareholders will receive $55.00 per share in cash, representing a $5 billion enterprise value transaction and a 54% premium to the 30-day VWAP. The transaction, the largest in the professional services sector in more than 25 years, was unanimously approved by the Board and is expected to close in Q4 2026 subject to shareholder approval and regulatory clearance.
View raw filing on EDGAR →In connection with the Merger Agreement, the Board adopted three compensatory arrangements: a Change-in-Control Severance Plan providing severance multiples of 0.5x–3x base salary plus bonus and health coverage for 6–36 months; a retention bonus program with 25% payable at closing and 75% at six months post-closing; and transaction bonuses totaling $1.302M, $812K, and $486K for the three named executives.
View raw filing on EDGAR →The filing discloses that management determined the Company's previously issued internal control reports as of December 31, 2025 should no longer be relied upon, and the auditor's opinion on internal control effectiveness will be amended to express an adverse opinion. Additionally, immaterial revisions are being made to the Q1 2026 condensed consolidated financial statements due to the inadvertent purchase of 481,049 shares in excess of ESPP authorization. While the revisions themselves are characterized as immaterial, the non-reliance on prior internal control conclusions and the restatement of interim financial statements constitute a restatement event under Item 4.02 principles.
View raw filing on EDGAR →CBIZ issued a press release on July 29, 2026 announcing financial results for the three and six months ended June 30, 2026, disclosing second-quarter and first-half revenue, net income, GAAP EPS, adjusted EBITDA, and adjusted diluted EPS. This is a standard earnings release filed under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1. While the filing also discloses a material merger agreement with Grant Thornton, the Item 2.02 section itself is centered on the quarterly and half-year financial results announcement.
View raw filing on EDGAR →NOV Inc. issued a press release on July 28, 2026 announcing second quarter 2026 earnings results, including revenues of $2.13 billion, net income of $112 million ($0.31 per share), and Adjusted EBITDA of $283 million. The press release is furnished as Exhibit 99.1 and incorporated by reference in Item 2.02, which is the standard Item for disclosure of quarterly financial results. This is a material earnings announcement for a public company's quarterly results.
View raw filing on EDGAR →The disclosure announces entry into a definitive Combination Agreement between SoftVest (a unitholder) and Blackbeard Holdings to combine the Trust's assets with Blackbeard's oil and natural gas operations to create a new publicly traded corporation, PBT Land and Minerals, Inc. This constitutes a material acquisition/change of control transaction subject to unitholder vote, directly falling under Item 1.01 (Material Agreements) and Item 2.01 (Completion of Acquisition or Disposition of Assets) categories, though disclosed under Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →Fidelity Private Credit Fund disclosed its financial results and performance as of June 30, 2026, including NAV per share of $24.72, total assets of $2.5 billion, and total net returns across multiple time periods (1-month, 3-month, YTD, 1-year, 3-year, and since inception), along with portfolio composition and distribution rates.
View raw filing on EDGAR →Macquarie Infrastructure Fund sold approximately $25.4 million of unregistered limited partnership units on July 1, 2026, to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D exemptions, representing a significant capital raise and expansion of the Fund's equity base.
View raw filing on EDGAR →The filing discloses the creation of a new direct financial obligation through the issuance of $1,289,740,000 in aggregate principal amount of asset-backed notes (Class A-1 through Class C) by Nissan Auto Lease Trust 2026-B pursuant to an Indenture dated the Closing Date. This is a material debt issuance involving multiple tranches of notes sold to underwriters, representing a substantial new financial obligation for the registrant.
View raw filing on EDGAR →Kirby Corporation issued a press release on July 29, 2026, announcing second quarter 2026 financial results, including net earnings of $89.7 million ($1.67 per share), total revenues of $922.4 million, and segment performance metrics. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases.
View raw filing on EDGAR →McGrath RentCorp disclosed its second quarter 2026 financial results via press release on July 29, 2026, reporting total revenues of $221.1 million (down 6% YoY), net income of $33.7 million ($1.37 per diluted share, down from $1.46), and updated full-year 2026 guidance. The filing is explicitly submitted under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →AIR Global announced a strategic equity investment of USD $20 million in Greentank Innovations through the purchase of preferred shares, plus a warrant to increase ownership by 20% over 24 months, along with board nomination rights and enhanced commercial terms. This constitutes a material acquisition or investment activity that would affect a reasonable investor's assessment of the company's capital allocation, strategic positioning, and growth strategy in the vaping and nicotine markets.
View raw filing on EDGAR →PTC announced third fiscal quarter 2026 results on July 29, 2026, with a press release furnished as Exhibit 99.1. The disclosure includes quarterly financial metrics (ARR, revenue, operating cash flow, free cash flow, EPS), management commentary on business performance, and updated full-year and Q4 guidance. This is a standard earnings release disclosing quarterly results and forward guidance.
View raw filing on EDGAR →Microsoft issued a press release on July 29, 2026 announcing financial results for the fiscal quarter and year ended June 30, 2026, disclosing revenue of $90.0 billion (up 18%) for Q4 and $331.8 billion (up 18%) for the full year, along with net income, operating income, and diluted EPS figures. This is a standard quarterly earnings release filed under Item 2.02 and furnished as Exhibit 99.1, which is the typical disclosure mechanism for earnings announcements.
View raw filing on EDGAR →Flowserve disclosed Q2 2026 financial results for the quarter ended June 30, 2026, reporting sales of $1.169 billion, operating margin of 13.0%, reported EPS of $0.77, and adjusted EPS of $0.95, along with bookings of $1.35 billion (up 26%) and updated full-year 2026 guidance raising the low end of adjusted EPS guidance to $4.05–$4.20.
View raw filing on EDGAR →Inhibikase issued a pre-funded warrant to acquire 18,030,000 shares of common stock without registration, relying on Section 3(a)(9) of the Securities Act. The warrant has a nominal $0.001 exercise price and is immediately exercisable, making it economically equivalent to a direct equity issuance. This is a classic dilutive unregistered equity transaction that would materially affect a reasonable investor's assessment of share dilution and capital structure.
View raw filing on EDGAR →Viking Therapeutics issued a press release on July 29, 2026, reporting financial results for the second quarter ended June 30, 2026, including R&D expenses of $115.8 million, G&A expenses of $16.9 million, and a net loss of $128.0 million ($1.10 per share). The disclosure includes detailed financial highlights and a corporate update on clinical pipeline progress, which is the hallmark of an earnings release under Item 2.02.
View raw filing on EDGAR →Pool Corporation's Board of Directors declared a quarterly cash dividend of $1.30 per share, payable August 27, 2026 to shareholders of record on August 13, 2026. This is a routine but material shareholder distribution that would affect investor assessment of capital allocation and shareholder returns.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) issued on July 29, 2026. The press release discloses revenue of $3.3 million, net loss of $2.6 million ($0.12 per diluted share), and detailed financial statements including consolidated statements of operations, balance sheets, and non-GAAP reconciliations. The filing explicitly states "Aware Reports Second Quarter Financial Results" and includes management commentary on operational performance and forward guidance.
View raw filing on EDGAR →The filing discloses that PowerCompute regained compliance with Nasdaq's minimum bid price requirement ($1.00 per share) after receiving a delisting notice on January 7, 2026, for failing to maintain the bid price for 30 consecutive business days. Although the company has now cured the deficiency and Nasdaq has closed the matter, the core event disclosed is the resolution of a delisting risk that threatened the company's continued listing on the Nasdaq Capital Market. This is material to investors as listing status directly affects liquidity, credibility, and market access.
View raw filing on EDGAR →Glaukos Corporation issued a press release on July 29, 2026 announcing Q2 2026 financial results, including record net sales of $185.6 million (50% year-over-year growth), gross margin of 82%, and raised full-year 2026 guidance to $680–$700 million.
View raw filing on EDGAR →This is a clear earnings release disclosing Medallion Financial Corp.'s quarterly financial results for Q2 2026. The Item 2.02 disclosure explicitly states the company "issued a press release to the news media announcing, among other things, the Company's results for the quarter ended June 30, 2026," with the press release attached as Exhibit 99.1. The release reports key metrics including net income of $7.4 million ($0.31 per share), net interest income of $57.2 million, record assets exceeding $3.0 billion, and loan originations growth of 63%, making it material to investors' assessment of the company's financial performance.
View raw filing on EDGAR →HCA Healthcare increased the size of its commercial paper program from $4.0 billion to $8.0 billion outstanding at any time, representing a material expansion of the issuer's direct financial obligations and borrowing capacity.
View raw filing on EDGAR →